Clinical Trial Update: Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating pevonedistat with cytarabine and idarubicin for various forms of acute myeloid leukemia, including therapy-related AML and A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia Arising From Prior Myelodysplastic Syndrome
• Acute Myeloid Leukemia with Myelodysplasia-related Changes
• Therapy-related Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Idarubicin (idarubicin)
• Pevonedistat (pevonedistat)

Snippet

Sponsor: University of Southern California | Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING